First 18f-Labeled Ligand for PET Imaging of uPAR: In Vivo Studies in Human Prostate Cancer Xenografts

Nuclear Medicine and Biology - United States
doi 10.1016/j.nucmedbio.2013.03.001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

First-In-Human uPAR PET: Imaging of Cancer Aggressiveness

Theranostics
MedicineToxicologyPharmaceuticsPharmacology
2015English

In Vitro and in Vivo Characterization of a 18f-AlF-Labeled PSMA Ligand for Imaging of PSMA-expressing Xenografts

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2019English

Molecular Imaging of Prostate Cancer With 18f-Fluorodeoxyglucose PET

Nature Reviews Urology
Urology
2009English

18f-FDG and 18f-FLT-Pet Imaging for Monitoring Everolimus Effect on Tumor-Growth in Neuroendocrine Tumors: Studies in Human Tumor Xenografts in Mice

PLoS ONE
Multidisciplinary
2014English

In Vitro and in Vivo Evaluation of a 18f-Labeled High Affinity NOTA Conjugated Bombesin Antagonist as a PET Ligand for GRPR-Targeted Tumor Imaging

PLoS ONE
Multidisciplinary
2013English

18F,64Cu, And68Ga Labeled RGD-Bombesin Heterodimeric Peptides for PET Imaging of Breast Cancer

Bioconjugate Chemistry
Organic ChemistryBiotechnologyPharmacologyPharmaceutical ScienceBioengineeringBiomedical Engineering
2009English

PET Imaging of Dll4 Expression in Glioblastoma and Colorectal Cancer Xenografts Using64Cu-Labeled Monoclonal Antibody 61B

Molecular Pharmaceutics
Drug DiscoveryMolecular MedicinePharmaceutical Science
2015English

Clinical PET Imaging in Prostate Cancer

Radiographics
MedicineNuclear MedicineRadiologyImaging
2017English

Convenient Preparation of 18f-Labeled Peptide Probes for Potential Claudin-4 PET Imaging

Pharmaceuticals
Molecular MedicinePharmaceutical Science
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy